Navigation Links
$100 Million Gift Launches Sanford Stem Cell Clinical Center
Date:11/4/2013

tely creating much-needed drugs and therapies," said Goldstein, who will also serve as director of the new Sanford Center. "We have made profound progress in understanding the basic nature and abilities of stem cells. We know a great deal about how they work and differentiate and, in a number of cases, how to make them become the kinds of cells we think we need. Now we have to put that knowledge to the test in people, for people."

A great deal of the progress in stem cell research has occurred at UC San Diego School of Medicine. For example:

  • Catriona H.M. Jamieson, MD, PhD, associate professor of medicine at UC San Diego School of Medicine and director of the UC San Diego Moores Cancer Center stem cell program, and colleagues are conducting or planning trials for several stem cell-derived treatments of leukemia and other blood diseases that have shown encouraging results in animal models and human clinical trials.
  • Mark H. Tuszynski, MD, PhD, professor in the UC San Diego Department of Neurosciences and director of the UC San Diego Translational Neuroscience Institute, investigates both the slowly evolving neurological damage of Alzheimer's disease and the sudden, catastrophic consequences of traumatic spinal cord injuries. In the latter work, Tuszynski and colleagues recently reported using introduced neural stem cells to regenerate axon growth at the site of severe spinal cord injuries in rats, restoring some movement.
  • Goldstein's lab has created, for the first time, stem cell-derived, in-vitro models of sporadic and hereditary Alzheimer's disease using induced pluripotent stem cells from patients with AD. These functional Alzheimer's neurons in a dish promise to be an unprecedented tool for developing and testing drugs to treat the dreaded neurodegenerative disorder.

The Sanford Stem Cell Clinical Center will adva
'/>"/>

SOURCE University of California, San Diego
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Spherix Announces Private Placement as the Company Continues to Execute its Patent Monetization Program - Spherix accepts $2.0 Million from Investors
2. Discovery Labs Prices $50 Million Public Offering of Common Stock
3. PathoGenetix Announces $10 Million Series C Financing
4. Immune Design Raises Up to $49 Million Series C Financing
5. CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million
6. Genufood Energy Enzymes Corp. Announces $20 Million Equity Purchase Agreement
7. NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q3 2013 Sales Of $664 Million, Organic Sales Growth Of 5% And Adjusted Diluted EPS Of $1.05. Reaffirms Full Year 2013 Organic Sales Outlook. Narrows Adjusted Diluted EPS Outlook To A New Range Of $4.08 To $4.15
9. Claritas Genomics to Sequence Exomes for VA Million Veteran Program with Ion Torrent Next-Generation Sequencers
10. Croda Inc Unveils $2.3 Million Investment in Solar
11. Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)...  Blueprint Medicines (NASDAQ: BPMC ) today ... of 9,367,708 shares of common stock at a ... shares of common stock issued upon the full ... purchase additional shares. The gross proceeds from the ... $168.6 million, before underwriting discounts and estimated offering expenses. ...
(Date:5/5/2015)... May 05, 2015 VetStem Biopharma, ... Animal Health, Jeffrey Schaffer, DVM, as Director of ... 15 years of experience in the veterinary regenerative ... addition to our veterinarian lead organization”. Dr. ... “Dr. Schaffer will be responsible for all technical ...
(Date:5/5/2015)... May 5, 2015  Tikcro Technologies Ltd. (OTCQB: ... to continue trading on OTCQB  Marketplace, the market ... Marketplace allows for a continuous public market for ... have real-time quotes and market information on us ... OTCQB Marketplace includes U.S. and international companies in ...
(Date:5/5/2015)... 5, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") ... , President and Chief Executive Officer, will present ... DATE:  Thursday, May 7, 2015     TIME:  11:30 am ... > click the red "register/ watch presentations" button ... online event where investors are invited to ask ...
Breaking Biology Technology:Blueprint Medicines Announces Closing of Initial Public Offering 2Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2
... ... Technology for In Situ Monitoring and Control of Complex Particle and Droplet Systems, which ... situ and in real time. , ... (PRWEB) March 10, 2010 -- When is turbidity not enough? For ...
... ... , ... ... , ...
... ... ... ... ...
Cached Biology Technology:Beyond Turbidity: Selecting Appropriate Technology for in Situ Monitoring and Control of Complex Particle and Droplet Systems 2IGEN Networks engages new auditors and converts debt 2A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward 2A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward 3A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward 4A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward 5A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward 6A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward 7A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward 8
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... -- At its 2015 ACMG Annual Clinical Genetics Meeting ... American College of Medical Genetics and Genomics (ACMG) announced ... Members of the ACMG Board of Directors serve as ... its policies and programs. ACMG is the national organization ... eventful time in medical genetics and genomics.  We are ...
(Date:3/31/2015)... 31, 2015  Elephant Talk Communications Corp. (NYSE MKT: ... of Software Defined Network Architecture (ET Software DNA® 2.0) ... of approximately $20.4 million for the year ended December ... for the year ended December 31, 2013. ... had completed its multi-year transition away from its legacy ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... used by a species of tropical seaweed to ward ... humans. The compounds are part of a unique chemical ... and that may provide a wealth of potential new ... at the Georgia Institute of Technology found that the ...
... note in the symphony of good news that usually ... promise in regenerative medicine, thanks to their ability to ... possible to markedly improve the effectiveness of many medical ... grafts for treating burn victims, and the treatment of ...
... of the parasitic worm that causes trichinosis, a disease ... wild game animals, such as bear and walrus. ... of Medicine in St. Louis and their collaborators report ... Trichinella spiralis , which provide potential targets for new ...
Cached Biology News:Antifungal compound found on tropical seaweed has promising antimalarial properties 2Antifungal compound found on tropical seaweed has promising antimalarial properties 3Antifungal compound found on tropical seaweed has promising antimalarial properties 4Reprogrammed stem cells hit a roadblock 2Trichinosis parasite gets DNA decoded 2
Mouse MMP-24 (MT5-MMP) MAb (Clone 143908)...
Normal sheep serum collected from healthy normal sheep...
TMB Slow Kinetic One Component HRP Microwell Substrate, 1 L...
Agarose-ME, 500 g. Suitable for immunoelectrophoresis.Gel point (1.5%): 36 1.5 C, EEO (-mr): 0.16-0.19, Gel strength (1%): > 1000 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Bio...
Biology Products: